首页 产品目录 分子砌块 按应用领域 分子与化学生命科学 生化试剂 甾体类 (6S,8R,9S,10R,13S,14S,17R)-17-乙酰基-17-羟基-6,10,13-三甲基-1,2,6,7,8,9,10,11,12,13,14,15,16,17-十四氢-3H-环戊并[a]菲-3-酮

(6S,8R,9S,10R,13S,14S,17R)-17-乙酰基-17-羟基-6,10,13-三甲基-1,2,6,7,8,9,10,11,12,13,14,15,16,17-十四氢-3H-环戊并[a]菲-3-酮

(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
100mg 98% 询价
- +
250mg 98% 询价
- +
1g 98% 询价
- +
5g 98% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

520-85-4

中文名称

(6S,8R,9S,10R,13S,14S,17R)-17-乙酰基-17-羟基-6,10,13-三甲基-1,2,6,7,8,9,10,11,12,13,14,15,16,17-十四氢-3H-环戊并[a]菲-3-酮

英文名称

(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one

别名

medroxyprogesterone | 520-85-4 | Medroxyprogesteron | Medroxiprogesteronum | Medroxiprogesterona | Medroxyprogesteronum | Medrossiprogesterone | 17-Hydroxy-6alpha-methylprogesterone | 17alpha-Hydroxy-6alpha-methylprogesterone | Hydroxymethylprogesterone | 6alpha-Methyl-17alp

标准英文名

(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one

MDL No.

MFCD00069474

分子式

C22H32O3

分子量

344.24

精确分子量

344.24

SMILES

C[C@@]12[C@](CC[C@]2(O)C(C)=O)([H])[C@@]3([H])[C@@](CC1)([H])[C@@]4(C([C@H](C3)C)=CC(CC4)=O)C

标准SMILES

CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C

用途

Medroxyprogesterone acetate (MPA) is used for the treatment of functional uterine bleeding, amenorrhea, and endometriosis caused by hormonal imbalances; as a contraceptive by inhibiting ovulation through suppression of luteinizing hormone (LH) release via negative feedback on the hypothalamus; in hormone replacement therapy during menopause to counteract the endometrial proliferative effects of estrogen; as palliative therapy for hormone-sensitive cancers including breast cancer, endometrial cancer, and prostate cancer; and for the management of symptoms in cancer patients, such as improving appetite, increasing body weight, and alleviating pain and other subjective symptoms.

InChIKey

FRQMUZJSZHZSGN-HBNHAYAOSA-N

安全信息

SureRoute逆合成路线

1.  520-85-4 逆合成路线 1

—
—
ACEFJT194
520-85-4
来源: SureRoute

2.  520-85-4 逆合成路线 2

—
—
ACEFJT194
520-85-4
来源: SureRoute

3.  520-85-4 逆合成路线 3

—
—
ACEFJT194
520-85-4
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手